Eli Lilly, which also will make the weight loss medicines Mounjaro and Zepbound, stated it designs to complete seven added period 3 medical trials of retatrutide in 2026, compiling information that can be submitted towards the U.Retatrutide shown significant improvements in body excess weight and metabolic results among the adults with weight probl